Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
70.9M
-
Shares change
-
+4.39M
-
Total reported value, excl. options
-
$638M
-
Value change
-
+$41.7M
-
Put/Call ratio
-
1.07
-
Number of buys
-
86
-
Number of sells
-
-70
-
Price
-
$9.00
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2024
181 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q2 2024.
Replimune Group, Inc. - COMMON STOCK (REPL) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.9M shares
of 78.4M outstanding shares and own 90.48% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.24M shares), Redmile Group, LLC (5.56M shares), FCPM III SERVICES B.V. (4.87M shares), BlackRock Inc. (4.71M shares), MILLENNIUM MANAGEMENT LLC (3.12M shares), VANGUARD GROUP INC (2.9M shares), Omega Fund Management, LLC (2.46M shares), Atlas Venture Life Science Advisors, LLC (2.1M shares), and MORGAN STANLEY (1.74M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.